Zobrazeno 1 - 10
of 71
pro vyhledávání: '"David H. Brewster"'
Autor:
David Weller, Lovney Kanguru, Christine Campbell, Annemieke Bikker, David H. Brewster, Karen Barnett, Debbie Cavers, Rhona Duff
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
BMC Cancer
Cavers, D, Campbell, C, Brewster, D, Weller, D, Bikker, A, Kanguru, L, Barnett, K & Duff, R 2021, ' Patient and GP experiences of pathways to diagnosis of a second primary cancer: a qualitative study ', BMC Cancer, vol. 21, no. 496, 496 . https://doi.org/10.1186/s12885-021-08238-0
BMC Cancer
Cavers, D, Campbell, C, Brewster, D, Weller, D, Bikker, A, Kanguru, L, Barnett, K & Duff, R 2021, ' Patient and GP experiences of pathways to diagnosis of a second primary cancer: a qualitative study ', BMC Cancer, vol. 21, no. 496, 496 . https://doi.org/10.1186/s12885-021-08238-0
Background More people are surviving a first primary cancer and experiencing a second, different cancer. However, little is known about the diagnostic journeys of patients with second primary cancer (SPC). This study explores the views of patients an
Publikováno v:
Ruiz de Azua Unzurrunzaga, G, Brewster, D H, Wild, S & Sivalingam, V N 2019, ' Declining Hysterectomy Prevalence and the Estimated Impact on Uterine Cancer Incidence in Scotland ', Cancer Epidemiology, vol. 59, pp. 227-231 . https://doi.org/10.1016/j.canep.2019.02.008
Ruiz de Azua Unzurrunzaga, G, Brewster, D H, Wild, S H & Sivalingam, V N 2019, ' Declining hysterectomy prevalence and the estimated impact on uterine cancer incidence in Scotland ', Cancer Epidemiology, vol. 59, pp. 227-231 . https://doi.org/10.1016/j.canep.2019.02.008
Ruiz de Azua Unzurrunzaga, G, Brewster, D H, Wild, S H & Sivalingam, V N 2019, ' Declining hysterectomy prevalence and the estimated impact on uterine cancer incidence in Scotland ', Cancer Epidemiology, vol. 59, pp. 227-231 . https://doi.org/10.1016/j.canep.2019.02.008
AIM: The prevalence of hysterectomy is decreasing worldwide. It is not clear whether changes in the population at risk (women with intact uteruses) have contributed to an increased uterine cancer incidence. This study aims to assess the effect of cha
Autor:
David H. Brewster, Laura Botta, Gemma Gatta, Jeremy Whelan, Anna Maria Frezza, Paolo G. Casali, Vincent K Y Ho, Annalisa Trama, Charles A. Stiller
Publikováno v:
Cancer Epidemiology. 56:146-153
Five-year relative survival (RS) of adults with bone and soft-tissue cancers in Europe was still60% by 1995-1999. There was large geographical survival variability, mainly for bone tumours, and survival decreased with increasing age at diagnosis.Data
Autor:
Sarah H Wild, Ines Mesa-Eguiagaray, Peter Hall, David H Brewster, Jonine D. Figueroa, David S. Morrison, Sheila M. Bird, David Cameron, Philip S. Rosenberg
Publikováno v:
Mesa-Eguiagaray, I, Wild, S H, Rosenberg, P S, Bird, S, Brewster, D, Hall, P, Cameron, D, Morrison, D & Figueroa, J 2020, ' Distinct temporal trends in breast cancer incidence from 1997 to 2016 by molecular subtypes : a population-based study of Scottish cancer registry data ', British Journal of Cancer, vol. 123, pp. 852–859 . https://doi.org/10.1038/s41416-020-0938-z
British Journal of Cancer
British Journal of Cancer
Background We describe temporal trends in breast cancer incidence by molecular subtypes in Scotland because public health prevention programmes, diagnostic and therapeutic services are shaped by differences in tumour biology. Methods Population-based
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f566972efdbd1b964c03735fd6a16373
https://www.pure.ed.ac.uk/ws/files/164480411/s41416_020_0938_z.pdf
https://www.pure.ed.ac.uk/ws/files/164480411/s41416_020_0938_z.pdf
Autor:
Ewan Gray, Joachim Marti, Jeremy C Wyatt, David H Brewster, Peter S Hall, SATURNE advisory group
Publikováno v:
PLoS Medicine, Vol 16, Iss 12, p e1003006 (2019)
PLoS Medicine
Gray, E, Marti, J, Wyatt, J C & Brewster, D H & Hall, P S 2019, ' Chemotherapy effectiveness in trial-underrepresented groups with early breast cancer : A retrospective cohort study ', PLoS Medicine, vol. 16, no. 12, e1003006 . https://doi.org/10.1371/journal.pmed.1003006
PLoS medicine, vol. 16, no. 12, pp. e1003006
PLoS Medicine
Gray, E, Marti, J, Wyatt, J C & Brewster, D H & Hall, P S 2019, ' Chemotherapy effectiveness in trial-underrepresented groups with early breast cancer : A retrospective cohort study ', PLoS Medicine, vol. 16, no. 12, e1003006 . https://doi.org/10.1371/journal.pmed.1003006
PLoS medicine, vol. 16, no. 12, pp. e1003006
Background Adjuvant chemotherapy in early stage breast cancer has been shown to reduce mortality in a large meta-analysis of over 100 randomised trials. However, these trials largely excluded patients aged 70 years and over or with higher levels of c
Autor:
Lidia Sacchetto, Anna Gavin, Harry Comber, Christine Bouchardy, Siri Larønningen, Jaume Galceran, E. Van Eycken, Roberto Zanetti, M-D Chirlaque, P. Broganelli, Vesna Zadnik, Sally Vernon, Laufey Tryggvadottir, Eileen Morgan, Alexander Katalinic, David H. Brewster, Stefano Rosso, Marieke W. Louwman, Monika Hackl, R. Tumino, D. Coza, Trude Eid Robsahm, M-J Sanchez
Publikováno v:
European Journal of Cancer, Vol. 92 (2018) pp. 108-118
Background We analysed trends in incidence for in situ and invasive melanoma in some European countries during the period 1995–2012, stratifying for lesion thickness. Material and methods Individual anonymised data from population-based European ca
Autor:
Luke Hounsome, Eilis McCaughan, Anna Gavin, Emma McNair, Majorie Allen, William Cross, Linda Sharp, Amy Downing, Hugh Butcher, James W.F. Catto, Eila Watson, Paul Kind, Richard Wagland, Peter Selby, Therese Kearney, Malcolm David Mason, Oonagh McSorley, Dyfed Wyn Huws, Sarah Wilding, Rebecca Mottram, David Weller, Penny Wright, Galina Velikova, David Donnelly, Adam Glaser, David H Brewster
Publikováno v:
Downing, A, Wright, P, Hounsome, L, Selby, P, Wilding, S, Watson, E, Wagland, R, Kind, P, Donnelly, D W, Butcher, H, Catto, J W F, Cross, W, Mason, M, Sharp, L, Weller, D, Velikova, G, McCaughan, E, Mottram, R, Allen, M, Kearney, T, McSorley, O, Huws, D W, Brewster, D H, McNair, E, Gavin, A & Glaser, A W 2019, ' Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study ', The Lancet Oncology, vol. 20, no. 3, pp. 436-447 . https://doi.org/10.1016/S1470-2045(18)30780-0
Downing, A, Wright, P, Hounsome, L, Selby, P, Wilding, S, Watson, E, Wagland, R, Kind, P, Donnelly, D W, Butcher, H, Catto, J W F, Cross, W, Mason, M, Sharp, L, Weller, D, Velikova, G, McCaughan, E, Mottram, R, Allen, M, Kearney, T, McSorley, O, Huws, D W, Brewster, D H, McNair, E, Gavin, A & Glaser, A W 2019, ' Quality of life in men living with advanced and localised prostate cancer in the UK a population-based study ', Lancet Oncology, vol. 20, no. 3, pp. 436-447 . https://doi.org/10.1016/S1470-2045(18)30780-0
Downing, A, Wright, P, Hounsome, L, Selby, P, Wilding, S, Watson, E, Wagland, R, Kind, P, Donnelly, D W, Butcher, H, Catto, J W F, Cross, W, Mason, M, Sharp, L, Weller, D, Velikova, G, McCaughan, E, Mottram, R, Allen, M, Kearney, T, McSorley, O, Huws, D W, Brewster, D H, McNair, E, Gavin, A & Glaser, A W 2019, ' Quality of life in men living with advanced and localised prostate cancer in the UK a population-based study ', Lancet Oncology, vol. 20, no. 3, pp. 436-447 . https://doi.org/10.1016/S1470-2045(18)30780-0
BACKGROUND: Little is known about the health-related quality of life (HRQOL) of men living with advanced prostate cancer. We report population-wide functional outcomes and HRQOL in men with all stages of prostate cancer and identify implications for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d63923dffa7c70b457c3ee7c8e910733
https://www.pure.ed.ac.uk/ws/files/180327021/AAM_Quality_of_life_in_men_living_with_advanced_and_localised_prostate_cancer.pdf
https://www.pure.ed.ac.uk/ws/files/180327021/AAM_Quality_of_life_in_men_living_with_advanced_and_localised_prostate_cancer.pdf
Autor:
Hugh Butcher, Therese Kearney, Luke Hounsome, Amy Downing, Anna Gavin, Peter Selby, Eila Watson, Penny Wright, Majorie Allen, Rebecca Mottram, Sarah Wilding, Dyfed Wyn Huws, David H. Brewster, Richard Wagland, Adam Glaser
Publikováno v:
Wright, P, Wilding, S, Watson, E, Downing, A, Selby, P, Hounsome, L, Wagland, R, Brewster, D H, Huws, D, Butcher, H, Mottram, R, Kearney, T, Allen, M, Gavin, A & Glaser, A W 2019, ' Key factors associated with social distress after prostate cancer: Results from the United Kingdom Life after Prostate Cancer diagnosis study ', Cancer Epidemiology . https://doi.org/10.1016/j.canep.2019.04.006
Background: more men are living following a prostate cancer (PCa) diagnosis. They may need support to maximize the quality of their survival. Physical and psychological impacts of PCa are widely documented. Less is known about social impacts. We aime
Autor:
G. Gatta, A. Trama, R. Capocaccia, Monika Hackl, Elizabeth Van Eycken, Kris Henau, Nadya Dimitrova, Mario Sekerija, Ladislav Dušek, Margit Mägi, Nea Malila, Maarit Leinonen, Michel Velten, Xavier Troussard, Veronique Bouvier, Anne-Valérie Guizard, Anne-Marie Bouvier, Patrick Arveux, Marc Maynadié, Anne-Sophie Woronoff, Michel Robaszkiewicz, Isabelle Baldi, Alain Monnereau, Brigitte Tretarre, Marc Colonna, Florence Molinié, Simona Bara, Claire Schvartz, Bénédicte Lapôtre-Ledoux, Pascale Grosclaude, Roland Stabenow, Sabine Luttmann, Alice Nennecke, Jutta Engel, Gabriele Schubert-Fritschle, Jan Heidrich, Bernd Holleczek, Jón Gunnlaugur Jónasson, Kerri Clough-Gorr, Harry Comber, Guido Mazzoleni, Adriano Giacomin, Antonella Sutera Sardo, Alessandro Barchielli, Diego Serraino, Roberta De Angelis, Sandra Mallone, Andrea Tavilla, Daniela Pierannunzio, Silvia Rossi, Mariano Santaquilani, Arnold Knijn, Fabio Pannozzo, Valerio Gennaro, Lucia Benfatto, Paolo Ricci, Mariangela Autelitano, Gianbattista Spagnoli, Mario Fusco, Mario Usala, Francesco Vitale, Maria Michiara, Rosario Tumino, Lucia Mangone, Fabio Falcini, Stefano Ferretti, Rosa Angela Filiberti, Enza Marani, Arturo Iannelli, Flavio Sensi, Silvano Piffer, Maria Gentilini, Anselmo Madeddu, Antonio Ziino, Sergio Maspero, Pina Candela, Fabrizio Stracci, Giovanna Tagliabue, Massimo Rugge, Annalisa Trama, Gemma Gatta, Laura Botta, Riccardo Capocaccia, Santa Pildava, Giedre Smailyte, Neville Calleja, Tom Børge Johannesen, Jadwiga Rachtan, Stanisław Góźdź, Jerzy Błaszczyk, Kamila Kępska, Forjaz de Lacerda, Maria José Bento, Ana Miranda, Chakameh Safaei Diba, Enrique Almar, Nerea Larrañaga, Arantza Lopez de Munain, Ana Torrella-Ramos, José María Díaz García, Rafael Marcos-Gragera, Maria Josè Sanchez, Carmen Navarro, Diego Salmeron, Conchi Moreno-Iribas, Jaume Galceran, Marià Carulla, Mohsen Mousavi, Christine Bouchardy, Silvia M. Ess, Andrea Bordoni, Isabelle Konzelmann, Jem Rashbass, Anna Gavin, David H. Brewster, Dyfed Wyn Huws, Otto Visser, Magdalena Bielska-Lasota, Maja Primic-Zakelj, Ian Kunkler, Ellen Benhamou
Rare cancers epidemiology is better known compared to the other rare diseases. Thanks to the long history of the European population-based cancer registries and to the EUROCARE huge database, the burden of rare cancers has been estimated the European
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5139fe28ffab91e999f7087ec9b88a15
http://hdl.handle.net/11392/2380545
http://hdl.handle.net/11392/2380545
ObjectiveAn association between detectable faecal haemoglobin (f-Hb) and both the risk of death from colorectal cancer (CRC) and all-cause mortality has been reported. We set out to confirm or refute this observation in a UK population and to explore
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3015da9666ca9b4e14c601eb81b6dc60
https://eprints.whiterose.ac.uk/156986/1/2116.full.pdf
https://eprints.whiterose.ac.uk/156986/1/2116.full.pdf